<DOC>
	<DOCNO>NCT00284050</DOCNO>
	<brief_summary>This study evaluate safety efficacy ranibizumab retinal edema visual acuity patient diabetic macular edema center involvement .</brief_summary>
	<brief_title>Safety Efficacy Ranibizumab Diabetic Macular Edema With Center Involvement</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Diabetic macular edema center involvement least one eye Type 1 type 2 diabetes mellitus diagnose 2 year prior screen Laser photocoagulation study eye withhold least 3 month randomization Patients uncontrolled systemic ocular disease Have history intraocular surgery study eye within past 6 month precede screening Conditions require chronic concomitant therapy systemic topical ocular corticosteroid Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>DME</keyword>
	<keyword>Diabetic macular edema</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>Diabetic macular edema center involvement</keyword>
</DOC>